Litcius/Paper detail

HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients

Joonho Shim, H.S. Kim, Hongui Cha, Soo‐Chan Kim, T.M. Kim, Valsamo Anagnostou, Yoon‐La Choi, Hyun Ae Jung, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, K. Park, W.-Y. Park, S.-H. Lee

2020Annals of Oncology149 citationsDOI

Topics & Concepts

MedicineLoss of heterozygosityImmunotherapyOncologyHuman leukocyte antigenLung cancerInternal medicineBiomarkerCancerBlockadeCancer researchAntigenImmunologyAlleleReceptorGeneticsGeneBiologyCancer Immunotherapy and Biomarkersvaccines and immunoinformatics approachesCAR-T cell therapy research
HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients | Litcius